Intestinal permeability in Crohn's disease

被引:0
|
作者
Meddings, JB [1 ]
机构
[1] Univ Calgary, Hlth Sci Ctr, Dept Med, Gastrointestinal Res Grp, Calgary, AB TN2 4N1, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Measurements of intestinal permeability (IP) may help in determining susceptibility for the development of Crohn's disease or for imminent relapse in patients with the disease. It is now apparent that a subset of patients at high risk for the development of Crohn's disease have either increased baseline IP or an exaggerated response to environmental agents that increase IP. These, coupled with observations that increased IP in patients at risk for the development of Crohn's disease is associated with an abnormal immunological phenotype, lend support to the hypothesis that increased IP is a very early event in the genesis of Crohn's disease.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 50 条
  • [31] Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission
    Vilela, Eduardo Garcia
    De Abreu Ferrari, Maria De Lourdes
    Da Gama Torres, Henrique Oswaldo
    Pinto, Ademar Guerra
    Carneiro Aguirre, Ana Carolina
    Martins, Fabiana Paiva
    Andrade Goulart, Eugenio Marcos
    Da Cunha, Aloisio Sales
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2008, 43 (07) : 842 - 848
  • [32] Tight Junction Proteins in the Maintenance of Intestinal Permeability in Patients With Celiac Disease and Crohn's Disease
    Goswami, Pooja
    Verma, Anil K.
    Das, Prasenjit
    Mishra, Asha
    Prakash, Shyam
    Das, Taposh K.
    Vishnubhatla, Sreenivas
    Gupta, Siddhartha Datta
    Ahuja, Vineet
    Makharia, Govind K.
    GASTROENTEROLOGY, 2013, 144 (05) : S243 - S243
  • [33] Gastroduodenal permeability in Crohn's disease
    Püspök, A
    Oberhuber, G
    Wyatt, J
    Maier-Dobersberger, T
    Hammer, J
    Pfeffel, F
    Wrba, F
    Pötzi, R
    Vogelsang, H
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1998, 28 (01) : 67 - 71
  • [34] Abnormal intestinal permeability predicts relapse in patients with inactive Crohn's disease.
    Arnott, IDR
    Ghosh, S
    Ferguson, A
    GASTROENTEROLOGY, 1998, 114 (04) : A923 - A923
  • [35] Oral immunoglobulin treatment improved intestinal permeability in children with active Crohn's disease
    Sundqvist, Tommy
    Stenhammar, Lars
    Tjellstrom, Bo
    Magnusson, Karl-Eric
    Forslund, Tony
    Hogberg, Lotta
    ACTA PAEDIATRICA, 2017, 106 (04) : 647 - 653
  • [36] Intestinal permeability is not predictive of endoscopic recurrence in patients operated on for Crohn's disease.
    Klein, O
    Houdret, N
    Desreumaux, P
    Gambiez, L
    Quandalle, P
    Cortot, A
    Colombel, JF
    GASTROENTEROLOGY, 1997, 112 (04) : A1016 - A1016
  • [37] Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk
    Irvine, EJ
    Marshall, JK
    GASTROENTEROLOGY, 2000, 119 (06) : 1740 - 1744
  • [38] Intestinal Permeability as a Clinical Surrogate Endpoint in the Development of Future Crohn's Disease Therapies
    Han, Xiaonan
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2010, 4 (02) : 159 - 176
  • [39] Abnormal intestinal permeability predicts relapse in patients with inactive Crohn's disease.
    Arnott, IDR
    GUT, 1998, 42 : A41 - A41
  • [40] Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease
    Hilsden, RJ
    Meddings, JB
    Sutherland, LR
    GASTROENTEROLOGY, 1996, 110 (05) : 1395 - 1403